Cariogenic potential of liquid medications in rats.
D000818:Animals; D001977:Brompheniramine / Q000008:administration & dosage; D002326:Cariogenic Agents / Q000009:adverse effects*; D003731:Dental Caries / Q000209:etiology*; D004338:Drug Combinations / Q000008:administration & dosage; D004809:Ephedrine / Q000008:administration & dosage; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage; D006863:Hydrogen-Ion Concentration; D008297:Male; D014677:Pharmaceutical Vehicles / Q000009:adverse effects*; D010656:Phenylephrine / Q000008:administration & dosage; D010665:Phenylpropanolamine / Q000008:administration & dosage; D054199:Pseudoephedrine; D051381:Rats; D011919:Rats, Inbred Strains; D013012:Sorbitol / Q000009:adverse effects; D013395:Sucrose / Q000009:adverse effects; D014311:Triprolidine / Q000008:administration & dosage
D002326:Cariogenic Agents; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D014677:Pharmaceutical Vehicles; C007484:brompheniramine, pseudoephedrine drug combination; C006399:pseudoephedrine, triprolidine drug combination; D010656:Phenylephrine; D014311:Triprolidine; D010665:Phenylpropanolamine; D013012:Sorbitol; D013395:Sucrose; D054199:Pseudoephedrine; D004809:Ephedrine; D001977:Brompheniramine